Publikacje


The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. E Przegaliński, E Moryl, M Papp
Neuropharmacology,
PMID:8570028

Poniedziałek, 4 Marca 1996
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity. J L Mokrosz, E Chojnacka-Wójcik, A Dereń-Wesołek, A Kłodzińska, M Maćkowiak, Z Bielecka, M H Paluchowska
Drug design and discovery,
PMID:7548635

Poniedziałek, 6 Listopada 1995
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. G Skuza, Z Rogoz, G Quack, W Danysz
Journal of neural transmission. General section,
PMID:7710739

Piątek, 12 Maja 1995
Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. J Maj, Z Rogóz, G Skuza, K Kołodziejczyk
Polish journal of pharmacology,
PMID:8000442

Środa, 25 Stycznia 1995
Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. J Maj, V Klimek, K Gołembiowska, Z Rogóz, G Skuza
Polish journal of pharmacology,
PMID:7912134

Czwartek, 28 Lipca 1994
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. V Klimek, J Zak-Knapik, M Mackowiak
Journal of psychiatry & neuroscience : JPN,
PMID:8148368

Piątek, 6 Maja 1994
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. A Czyrak, G Skuza, Z Rogóz, T Frankiewicz, J Maj
Arzneimittel-Forschung,
PMID:7511901

Środa, 4 Maja 1994